PATH-19. MOLECULAR, HISTOLOGIC AND CLINICAL CHARACTERISTICS OF OLIGODENDROGLIOMAS: A MULTI-INSTITUTIONAL RETROSPECTIVE STUDY

In the 2016 WHO classification of CNS tumors, oligodendrogliomas are molecularly defined by IDH1 or IDH2 mutations and 1p/19q co-deletion. Some reports suggest that PI3K pathway alterations may confer increased risk of progression and poor prognosis in oligodendroglioma. However, factors that influe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Dono, Antonio, Alfaro-Munoz, Kristin, Yan, Yuanqing, Lopez-Garcia, Carlos, Soomro, Zaid, Williford, Garret, Takayasu, Takeshi, Robell, Lindsay, Majd, Nazanin, de Groot, John, Esquenazi, Yoshua, Kamiya-Matsuoka, Carlos, Ballester, Leomar Y
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Molecular Pathology & Classification
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650919/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.701
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares